RASHMI KRISHNA MURTHY to Stroke Volume
This is a "connection" page, showing publications RASHMI KRISHNA MURTHY has written about Stroke Volume.
Connection Strength
0.034
-
Initial safety analysis of a randomized phase II trial of nelipepimut-S?+?GM-CSF and trastuzumab compared to trastuzumab alone to prevent recurrence in breast cancer patients with HER2 low-expressing tumors. Clin Immunol. 2019 04; 201:48-54.
Score: 0.034